Hypertension? Too much cholesterol? Then try a trade mark licence

PR Newswire reports that Merck Serono, a division of the German pharma giant Merck KGaA, has signed a distribution agreement with Bristol-Myers Squibb for a portfolio of established pharmaceutical brands in Latin America.

This agreement gives Merck Serono the exclusive marketing and distribution rights to more than 30 prescription medicines, particularly in the cardio-metabolic field, in Argentina, Chile, Colombia, Ecuador, Panama, Peru and Venezuela. Sales of these medicines last year topped US$90 million. Products featured in the deal include well-established brands such as Pravachol for the treatment of high cholesterol levels and Monopril, an ACE-inhibitor used in the field of hypertension.